Rep. Lemmons offered the following resolution:

            House Resolution No. 378.

            A resolution to memorialize the Congress of the United States and the appropriate federal officials to take the steps necessary to reclassify marijuana from a schedule I to a schedule II drug.

            Whereas, The federal government, through statute and rule, classifies drugs through a highly developed series of schedules. These schedules reflect the wide variety of effects of drugs, the diversity of their use as medicines, and the potential for harm that their misuse could have; and

            Whereas, Marijuana is currently listed as a Schedule I drug. Criteria for drugs in Schedule I include the following factors:

(A) The drug or other substance has a high potential for abuse.

(B) The drug or other substance has no currently accepted medical use in treatment in the United States.

(C) There is a lack of accepted safety for use of the drug or other substance under medical supervision.

The criteria for drugs listed in Schedule II include:

(A) The drug or other substance has a high potential for abuse.

(B) The drug or other substance has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions.

(C) Abuse of the drug or other substances may lead to severe psychological or physical dependence

; and

            Whereas, With the growing recognition of the medicinal use of marijuana and the increasing number of states and localities that provide for this use, there are many who feel that marijuana should be reevaluated at the federal level and should be identified as a Schedule II drug. Studies that have demonstrated marijuana's therapeutic properties in the treatment of certain conditions indicate that a reclassification is in order; and

            Whereas, There are a variety of measures that can be taken to reclassify a drug. Congress can amend the Controlled Substances Act; the Drug Enforcement Administration and Food and Drug Administration together can reschedule a drug if clinical trials support the move; the United States Secretary of Health and Human Services can issue a binding recommendation to the United States Attorney General; or the Attorney General can initiate rescheduling under certain conditions; now, therefore, be it

            Resolved by the House of Representatives, That we memorialize the Congress of the United States, the United States Attorney General, the United States Secretary of Health and Human Services, the Drug Enforcement Administration, and the Food and Drug Administration to take the steps necessary to reclassify marijuana from a schedule I to a schedule II drug; and be it further

            Resolved, That copies of this resolution be transmitted to the President of the United States Senate, the Speaker of the United States House of Representatives, the members of the Michigan congressional delegation, the United States Attorney General, the United States Secretary of Health and Human Services, the Drug Enforcement Administration, and the Food and Drug Administration.